Financhill
Back

CRISPR Therapeutics AG Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
61

CRSP
CRISPR Therapeutics AG

Last Price:
48.80
Seasonality Move:
18.54%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

CRISPR Therapeutics AG Stock Forecast

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 23.8% based on the past 8 years of stock performance.
  • CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is CRISPR Therapeutics AG Stock Undervalued?
    The current CRISPR Therapeutics AG [CRSP] share price is $49.79. The Score for CRSP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will CRISPR Therapeutics AG Stock Go Up Next Year?

  • Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 23.8% based on the past 8 years of stock performance.

CRISPR Therapeutics AG Stock Rating

Buy
61
CRISPR Therapeutics AG (CRSP) is a Buy

Is CRISPR Therapeutics AG overpriced?

  • CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

CRISPR Therapeutics AG Stock Price History

Is CRSP stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com

52-Week Data

52-Week High:
91.10
52-Week Low:
43.42

Prediction Charts

Market Cap:
4.25B
Price in USD:
49.79
Volume:
1.85M
Beta:
1.99

Technical Analysis

SMA50:
47.73
SMA100:
50.23
SMA200:
57.77
52-Wk Change:
-4.27%

Stock Predictions

  • Is CRISPR Therapeutics AG stock public?
    Yes, CRISPR Therapeutics AG is a publicly traded company.
  • What is the CRISPR Therapeutics AG stock quote today?
    The CRISPR Therapeutics AG stock price is 49.79 USD today.
  • How to buy CRISPR Therapeutics AG stock online?
    You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 47.96 47.36 48.88 47.26
Oct-28 47.99 49.71 50.50 47.75
Oct-29 49.53 48.94 49.75 48.44
Oct-30 48.51 47.93 49.87 47.60
Oct-31 47.76 46.38 47.99 46.30
Nov-1 46.96 50.76 50.85 46.91
Nov-4 50.44 50.62 51.90 49.21
Nov-5 49.35 50.36 50.42 47.04
Nov-6 51.80 50.72 51.88 49.39
Nov-7 51.40 51.88 53.26 51.15
Nov-8 51.21 51.59 52.52 50.60
Nov-11 53.13 54.86 59.07 53.00
Nov-12 53.80 50.73 53.99 50.53
Nov-13 50.90 49.79 52.43 49.41

CRISPR Therapeutics AG Earnings

CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.

CRISPR Therapeutics AG Forecast Revenue Growth

CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.

* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.